KIORA PHARMACEUTICALS, INC. Shareholders' Equity
KIORA PHARMACEUTICALS, INC. (KPRX) had Shareholders' Equity of $16.86 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-07
- 2026-06-30: Stockholders' Equity Attributable to Parent $16.86M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $13.93M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $16.13M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $22.41M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $16.86M 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $13.93M 10-Q · filed 2026-08-07 | |
| 2025-12-31 | $16.13M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $22.41M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $22.13M 10-Q · filed 2026-08-07 | |
| 2025-03-31 | $23.70M 10-Q · filed 2026-08-07 | $23.70M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $25.76M 10-Q · filed 2026-08-07 | |
| 2024-09-30 | $30.03M 10-Q · filed 2025-11-07 | |
| 2024-06-30 | $33.10M 10-Q · filed 2025-11-07 | |
| 2024-03-31 | $34.90M 10-Q · filed 2025-08-08 | |
| 2023-12-31 | $6.11M 10-K · filed 2026-03-25 | |
| 2023-09-30 | $8.10M 10-Q · filed 2024-11-08 | |
| 2023-06-30 | $13.64M 10-Q · filed 2024-11-08 | |
| 2023-03-31 | $10.16M 10-Q · filed 2024-08-09 | |
| 2022-12-31 | $11.41M 10-K · filed 2025-03-25 | |
| 2022-09-30 | $10.52M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $8.76M 10-Q · filed 2023-11-09 | |
| 2022-03-31 | $11.26M 10-Q · filed 2023-08-08 | |
| 2021-12-31 | $14.58M 10-K · filed 2024-03-25 | $9.22M 10-K · filed 2022-04-15 |
| 2021-09-30 | $20.51M 10-Q · filed 2022-11-09 | $17.35M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $13.68M 10-Q · filed 2022-11-09 | $10.45M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $15.99M 10-Q · filed 2022-08-12 | $12.69M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $9.73M 10-K · filed 2023-03-23 | $7.00M 10-K · filed 2021-03-25 |
| 2020-09-30 | $5.96M 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $7.80M 10-Q · filed 2021-11-15 | |
| 2020-03-31 | $9.32M 10-Q · filed 2021-08-12 | |
| 2019-12-31 | $6.62M 10-K/A · filed 2022-07-07 | |
| 2019-09-30 | $5.21M 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $8.47M 10-Q · filed 2020-11-09 | |
| 2019-03-31 | $10.04M 10-Q · filed 2020-08-06 | |
| 2018-12-31 | $8.94M 10-K · filed 2021-03-25 | |
| 2018-09-30 | $11.10M 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $13.55M 10-Q · filed 2019-11-07 | |
| 2018-03-31 | $5.28M 10-Q · filed 2019-08-08 | |
| 2017-12-31 | -$1.93M 10-K · filed 2020-03-04 | |
| 2017-09-30 | $679.45K 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $4.57M 10-Q · filed 2017-08-04 | |
| 2017-03-31 | -$1.15M 10-Q · filed 2017-05-05 | |
| 2016-12-31 | -$329.42K 10-K · filed 2018-03-02 | |
| 2016-09-30 | $3.25M 10-Q · filed 2016-11-01 | |
| 2016-06-30 | $6.47M 10-Q · filed 2016-08-10 | |
| 2016-03-31 | $6.67M 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $6.09M 10-K · filed 2017-02-23 | |
| 2015-09-30 | $8.68M 10-Q · filed 2015-11-12 | |
| 2015-06-30 | $913.71K 10-Q · filed 2015-08-12 | |
| 2015-03-31 | $2.13M 10-Q · filed 2015-05-18 | |
| 2014-12-31 | -$46.81M 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |